Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen, a protein in the blood that doctors routinely monitor for cancer progression.
Chronic psychological stress can help tumors evade immune attack through a chain of molecular events involving gut bacteria and viruses within those bacteria.
Loss of GATA6 – a transcription factor that controls which genes are turned on or off – can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors.
The Center for Technology Licensing brought together Cornell inventors in Ithaca and at Weill Cornell Medicine for Bearers of Innovation: A One Cornell Celebration, recognizing CTL-connected inventors from the past two fiscal years.
Weill Cornell Medicine anesthesiologist Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an agency that monitors the universal right to freedom of religion or belief.
A new single-protein analysis technique gives researchers an unprecedented ability to study scramblases, and could someday be useful in devising new strategies against multiple diseases.
Ceremonies on Cornell’s Ithaca and Weill Cornell Medicine campuses honored not only academic achievement, but the resilience, shared purpose and commitment to lifelong learning that define Cornell staff.
Cornell Prime dots – known as C’ dots – are effective against prostate tumors, according to a new preclinical study led by investigators at Weill Cornell Medicine and the Cornell Duffield College of Engineering.
A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.
